Cleared Traditional

K972371 - ICEL ULTRASONIC NEBULIZER MODELS PU 12000 AIR AND PU 12300 AIR

K972371 is an FDA 510(k) clearance for ICEL ULTRASONIC NEBULIZER MODELS PU 120..., manufactured by Brasamerica Medical Equipment, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K972371 · Brasamerica Medical Equipment, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
55d
Days
Class 2
Risk

K972371 is an FDA 510(k) clearance for the ICEL ULTRASONIC NEBULIZER MODELS PU 12000 AIR AND PU 12300 AIR. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Brasamerica Medical Equipment, Inc. (Great Neck,, US). The FDA issued a Cleared decision on August 19, 1997 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Brasamerica Medical Equipment, Inc. devices

FDA 510(k) Submission Details - K972371

510(k) Number K972371 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 1997
Decision Date August 19, 1997
Days to Decision 55 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 140d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 247
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K972371.
SPACE CHAMBER FOR MODEL NUMBER AND ACCESSORIES
K971808 · Monarch Medical · Sep 1997
SODIUM CHLORIDE INHALATION SOLUTION, USP
K972466 · Holopack International, LP · Aug 1997
STERILE WATER FOR INHALATION, USP
K972467 · Holopack International, LP · Aug 1997
MDILOG, MODEL MDC-511
K970344 · Medtrak Technologies, Inc. · Aug 1997
PORT-NEB
K971933 · Medic-Aid , Ltd. · Aug 1997
HAND HELD MEDISPACER
K972237 · Thayer Medical Corp. · Jul 1997